Pharmacogenetics: optimising prescribing in primary care

Youssef, Essra; Thornley, Tracey; Guchelaar, Henk‐Jan; Wright, David J

doi:10.1002/psb.1982

Authors

Essra Youssef

TRACEY THORNLEY Tracey.Thornley1@nottingham.ac.uk
Professor of Health Policy

Henk‐Jan Guchelaar

David J Wright

Abstract

Pharmacogenetic (PGx) testing to personalise prescribing of certain medicines can improve patient outcomes and reduce adverse drug reactions. This article summarises the key findings of the PGx Impact study, designed to estimate the impact of pre-emptive genetic testing on prescribing, and discusses potential ways in which pharmacogenetic testing may optimise primary care prescribing in the near future.

Citation

Youssef, E., Thornley, T., Guchelaar, H., & Wright, D. J. (2022). Pharmacogenetics: optimising prescribing in primary care. Prescriber, 33(5), 10-13. https://doi.org/10.1002/psb.1982

Journal Article Type	Article
Acceptance Date	May 13, 2022
Online Publication Date	May 18, 2022
Publication Date	2022-05
Deposit Date	Jan 16, 2023
Publicly Available Date	May 19, 2023
Journal	Prescriber
Print ISSN	0959-6682
Electronic ISSN	1931-2253
Publisher	Wiley
Peer Reviewed	Peer Reviewed
Volume	33
Issue	5
Pages	10-13
DOI	https://doi.org/10.1002/psb.1982
Keywords	Pharmacology (medical); Pharmacology (nursing)
Publisher URL	https://wchh.onlinelibrary.wiley.com/doi/10.1002/psb.1982